Alyeska Investment Group
CGON icon

Alyeska Investment Group’s CG Oncology CGON Stock Holding History

Alyeska Investment Group’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.39M Buy
+61,729
New +$4.04M 0.01% 514
2025
Q3 		– Sell
-150,000
Closed -$3.9M – 606
2025
Q2 		$3.9M Buy
+150,000
New +$3.61M 0.01% 440
2025
Q1 		– Sell
-45,000
Closed -$1.29M – 528
2024
Q4 		$1.29M Buy
+45,000
New +$1.54M ﹤0.01% 488

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Alyeska Investment Group's CGON Position: Q2 2026 in Review

Alyeska Investment Group opened a new position in CG Oncology (CGON) in Q2 2026: 61,729 shares worth $4.39M. The stake represents 0.01% of the portfolio and ranks #514 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in CGON as recently as Q2 2025.

Alyeska Investment Group first reported a position in CGON in Q4 2024 and has held it in 3 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Alyeska Investment Group held 61,729 shares of CG Oncology worth $4.39M as of Q2 2026.
  • CG Oncology was a new Alyeska Investment Group position in Q2 2026.
  • CG Oncology made up 0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #514 holding.
  • Alyeska Investment Group first reported a position in CG Oncology in Q4 2024 and has held it in 3 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.